[Fombonne J, Devouassoux-Shisheboran M, Bouvier R, Droz J-P, Benahmed M, Krantic S. Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation. Cancer Detect Prev 2005; 29: 1-7.10.1016/j.cdp.2004.08.005]Search in Google Scholar
[Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova RF. Solid tumors in young children in Moscow Region of Russian Federation. Radiol Oncol 2008; 42: 39-44.10.2478/v10019-007-0037-2]Search in Google Scholar
[Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Tumours of the testis and paratesticular tissue. In: Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumour. Lyon: IARC Press; 2004. p. 217-78.]Search in Google Scholar
[Bergthorsson JT, Agnarsson BA, Gudbjartsson T, Magnusson K, Thoroddsen A, Palsson B, et al. A genome-wide study of allelic imbalance in human testicular germ cell tumors using microsatellite markers. Cancer Genet Cytogenet 2006; 164: 1-9.10.1016/j.cancergencyto.2005.06.015]Search in Google Scholar
[von Eyben FE. Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet Cytogenet 2004; 151: 93-138.10.1016/j.cancergencyto.2003.09.008]Search in Google Scholar
[Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 1997; 237: 1-6.10.1006/excr.1997.3776]Search in Google Scholar
[Bartkova J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Deregulation of the G1/S-phase control in human testicular germ cell tumours. APMIS 2003; 111: 252-66.10.1034/j.1600-0463.2003.1110129.x]Search in Google Scholar
[Adams PD, Li X, Sellers WR, Baher KB, Leng X, Harper JW, et al. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complex. Mol Cell Biol 1999; 19: 1068-80.10.1128/MCB.19.2.1068]Search in Google Scholar
[Parry D, Mahony D, Willis K, Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999; 19: 1775-83.10.1128/MCB.19.3.1775]Search in Google Scholar
[Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-77.10.1126/science.274.5293.1672]Search in Google Scholar
[Zhang HS, Postigo AA, Dean DC., Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFβ, and contact inhibition. Cell 1999; 97: 53-61.10.1016/S0092-8674(00)80714-X]Search in Google Scholar
[Bartkova J, Lukas C, Sørensen CS, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, et al. Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol 2003; 200: 149-56.10.1002/path.1353]Search in Google Scholar
[Schmidt BA, Rose A, Steinhoff C, Strohmeyer T, Hartman M, Ackermann R. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res 2001; 61: 4214-21.]Search in Google Scholar
[Herranz M, Urioste M, Santos J, Rivas C, Martinez B, Benitez J, et al. Analysis of the INK4a/ARF locus in non-Hodkin's lymphomas using two new internal microsatellite markers. Leukemia 1999; 13: 808-10.10.1038/sj.leu.2401409]Search in Google Scholar
[Xing EP, Yang G-Y, Wang L-D, Shi ST, Yang CS. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Clin Cancer Res 1999; 5: 1231-40.]Search in Google Scholar
[Jones PA, Laird PW. Cancer epigenetics comes of age. Nature Genet 1999; 21: 163-67.10.1038/5947]Search in Google Scholar
[Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 2003; 22: 461-66.10.1038/sj.onc.1206119]Search in Google Scholar
[Chaubert P, Guillou L, Kurt A-M, Bertholet M-M, Metthez G, Leisinger H-J. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors. Am J Pathol 1997; 151: 859-65.]Search in Google Scholar
[Heidenreich A, Gaddipati JP, Moul JW, Srivastava S. Molecular analysis of P16Ink4/CDKN2 and P15Ink4B/MTS2 genes in primary human testicular germ cell tumors. J Urol 1998; 159: 1725-30.10.1097/00005392-199805000-00101]Search in Google Scholar
[Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LHJ, Friedlander ML. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer 2000; 83: 729-36.10.1054/bjoc.2000.1334]Search in Google Scholar
[Vladušić T, Hrašćan R, Vrhovac I, Krušlin B, Gamulin M, Grgić M, et al. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors. Pathol Res Pract 2010; 206: 163-7.10.1016/j.prp.2009.10.007]Search in Google Scholar
[Jones RH, Vasey PA. New directions in testicular cancer; molecular determinants of oncogenesis and treatment success. Eur J Cancer 2003; 39: 147-56.10.1016/S0959-8049(02)00612-3]Search in Google Scholar
[Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci 1991; 88: 6662-6.10.1073/pnas.88.15.6662]Search in Google Scholar
[Peng H-Q, Bailey D, Bronson D, Goss PE, Hogg D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 1995; 55: 2871-75.]Search in Google Scholar
[Rothe M, Albers P, Wernert N. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol 1999; 188: 389-94.10.1002/(SICI)1096-9896(199908)188:4<389::AID-PATH364>3.0.CO;2-K]Search in Google Scholar
[Heidenreich A, Sesterhenn IA, Mostof FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998; 83: 1002-11.10.1002/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.0.CO;2-A]Search in Google Scholar
[Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Chk2 tumor suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene 2001; 20: 5897-902.10.1038/sj.onc.1204746]Search in Google Scholar
[Kamensek U, Sersa G. Targeted gene therapy in radiotherapy. Radiol Oncol 2008; 42: 115-35.10.2478/v10019-008-0009-1]Search in Google Scholar